IR Press Releases

SKR Shows 2024 Net Profit of 664 Million Baht Total operating income of 6,092 million baht The Board of Directors approved the allocation of profit of 411.57 million baht, paid a dividend of 0.20 baht/share, and announced a share buyback of 700 million baht.

Mr. Suriyan Kojaroj Executive Vice President and Chief Operating Officer Sikarin Public Company Limited or SKR disclosed its 2024 operating performance as a net profit of 664 million baht. Along with sweeping the revenue from medical treatment at 6,023.60 million baht. An increase of 4.08% compared to the same period last year. Despite facing pressure from the reduction of inpatient medical service rates for high-cost diseases. (AdjRW>2) of the Social Security Office, which affected the total revenue of 315.72 million baht. However, the Company was able to expand the revenue base of cash customers, especially the treatment of complex diseases, through specialized medical institutions to continue to grow, along with continuing to focus on managing costs and risks to be the most efficient, allowing the Company to maintain a net profit margin at 10.92% and expand its total asset base by 4.04% to Baht 9,619 million. Meanwhile, the liquidity ratio improved to 2.82 times, reflecting strong financial potential and the ability to continue to expand the business

Recently, the Board of Directors (Board) resolved to allocate a profit of 411.57 million baht and pay a dividend of 0.20 baht per share . In the event that the Company's share price is lower than its intended value, the implementation of the share buyback program will have a positive impact on the share price. SKR's share buyback program demonstrates strong cash flow and fundamentals

Mr. Suriyan added that for 2025, the company is preparing to expand its medical capabilities through the Center of Excellence along with the development of social security customer services through SSO Plus, as well as mobile hospital services through Sikarin Connect nationwide, in order to become the leading hospital in the treatment of complex diseases in Thailand. Driving strong growth and creating good returns for shareholders

Source: กรุงเทพธุรกิจ